4-Hydroxytamoxifen (Afimoxifene)

製品コードS7827 バッチS782704

印刷

化学情報

Synonyms

Afimoxifene

Storage
(From the date of receipt)

3 years -20°C powder
1 years -80°C in solvent

化学式

C₂₆H₂₉NO₂

分子量

387.51

CAS No.

68392-35-8

Solubility (25°C)*

体外

DMSO

390 mg/mL (1006.42 mM)

Water

Insoluble

Ethanol

Insoluble

体内（毎回新しく調製した物を用意してください）

Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 40%PEG300 2 5%Tween80 3 50%ddH2O この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。	7.500mg/ml (19.35mM)	Taking the 1 mL working solution as an example, add 50 μL of 150 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.

* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	4-Hydroxytamoxifen (Afimoxifene) is the active metabolite of tamoxifen and a selective estrogen receptor (ER) modulator that is widely used in the therapeutic and chemopreventive treatment of breast cancer.
in vitro	4-OHT is a potent activator of ER and has been shown to have a higher affinity for estrogen receptors. It has significant dose and time-dependent direct effects to alter the contractile function of isolated adult rat cardiac myocytes^[1]. 4-HT activates on-target modification frequency for intein-Cas9 variants ^[3].

プロトコル(参考用のみ)

細胞アッセイ	細胞株	Adult Rat and Mouse Cardiac Myocytes
	濃度	0, 0.5, 1, 3, 5, and 10 µM
	反応時間	15-45 min
	実験の流れ	For sarcomere length measurements, cells are covered in Tyrode’s containing 4OHT, allowed to reach 36 ± 1°C, and then stimulated at 0.2 Hz.
動物実験	動物モデル	Sprague-Dawley rats
	投薬量	21 mg/kg, 54 μmol/kg
	投与方法	oral administration

参考

https://pubmed.ncbi.nlm.nih.gov/24205315/
https://pubmed.ncbi.nlm.nih.gov/10190564/
https://pubmed.ncbi.nlm.nih.gov/25848930/

カスタマーフィードバック

: , , Oncogene, 2016, 36(16):2255-2264

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies [ Signal Transduct Target Ther, 2025, 10(1):97]	PubMed: 40133264
Interplay of ferroptotic and apoptotic cell death and its modulation by BH3-mimetics [ Cell Death Differ, 2025, 10.1038/s41418-025-01514-7]	PubMed: 40301648
EZH2 inhibition mitigates HIV immune evasion, reduces reservoir formation, and promotes skewing of CD8+ T cells toward less-exhausted phenotypes [ Cell Rep, 2025, 44(5):115652]	PubMed: 40333189
Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma [ Nat Commun, 2024, 15(1):8641]	PubMed: 39366996
The secreted protein Amuc_1409 from Akkermansia muciniphila improves gut health through intestinal stem cell regulation [ Nat Commun, 2024, 15(1):2983]	PubMed: 38582860
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma [ Cell Rep Med, 2024, 5(3):101468]	PubMed: 38508144
LKB1 prevents ILC2 exhaustion to enhance antitumor immunity [ Cell Rep, 2024, S2211-1247(23)01591-7]	PubMed: 38670109
The ARID1A-METTL3-m6A axis ensures effective RNase H1-mediated resolution of R-loops and genome stability [ Cell Rep, 2024, 43(2):113779]	PubMed: 38358891
Macrophages Promote Subtype Conversion and Endocrine Resistance in Breast Cancer [ Cancers (Basel), 2024, 16(3)678]	PubMed: 38339428
P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells [ Cancer Genomics Proteomics, 2024, 21(5):511-522]	PubMed: 39191497

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。